![Daniel W. Kollin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel W. Kollin
Corporate Officer/Principal chez
BioMed Capital Group Ltd.
Profil
Daniel W.
Kollin was re-appointed a Director of American Bio Medica Corp.
in January 2004 and was a Director from February 2003 to September 2003.
He has been Managing Director of BioMed Capital Group Ltd. since 1990 and is a Director of IsoTis, Inc. Mr. Kollin received an MBA from The Wharton School of The University of Pennsylvania.
Postes actifs de Daniel W. Kollin
| Sociétés | Poste | Début |
|---|---|---|
BioMed Capital Group Ltd. | Corporate Officer/Principal | 01/01/1990 |
Anciens postes connus de Daniel W. Kollin
| Sociétés | Poste | Fin |
|---|---|---|
| AMERICAN BIO MEDICA CORPORATION | Directeur/Membre du Conseil | 03/08/2009 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
American Bio Medica Corp.
 American Bio Medica Corp. Medical SpecialtiesHealth Technology Manufactures, develops and sells immunoassay diagnostic test kits | Health Technology |
BioMed Capital Group Ltd. |
